News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Industry News Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe August 01, 2025
News Conference News SCCT 2025 Cardiologists More Often Send Higher-Risk Patients for CAC Scans vs Generalists Yael L. Maxwell July 29, 2025
News Conference News SCCT 2025 Air Pollution in Canada Ups CAC, Total Plaque, and Obstructive CAD Yael L. Maxwell July 25, 2025
News Conference News SCCT 2025 Adding Coronary CT Angiography to Annual Firefighter Physicals Could Save Lives Yael L. Maxwell July 18, 2025
News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits Michael O'Riordan July 14, 2025
News Daily News Roughly Half of Patients Don’t Have Symptoms Prior to a First MI Todd Neale July 09, 2025
News Daily News Prepregnancy CV Health Portends Midlife Risks: CARDIA Analysis L.A. McKeown June 27, 2025
News Daily News Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes Michael O'Riordan June 20, 2025
News Daily News Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes Todd Neale June 13, 2025
News Industry News Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels June 12, 2025
News Daily News Pressure-Based Physiological Testing Results Diverge Between LAD, LCx Caitlin E. Cox May 29, 2025
News Conference News EuroPCR 2025 Early Coronary Function Testing Improves Quality of Life in ANOCA Yael L. Maxwell May 28, 2025
News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Conference News EuroPCR 2025 Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data Yael L. Maxwell May 20, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025